Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Sells $750M in Senior Notes

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that it had sold a total of $750 million worth of senior notes through two offerings.

The firm said that it issued $450 million worth of 3.2 percent senior notes due 2015 and $300 million of 4.7 percent senior notes due 2020. The notes mature on May 1 of their respective years. Interest is payable twice a year on Nov. 1 and May 1, beginning with Nov. 1 2010.

Thermo Fisher said last week that proceeds from the $750 million notes offerings will be used to redeem all outstanding 6-1/2 percent senior subordinated notes due 2015 at a redemption price of $1,030.63 per $1,000 on July 1, 2010.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.